Robert F Apple's Net Worth
$20.5 Million
Who is Robert F Apple?
Robert F Apple has an estimated net worth of $20.5 Million. This is based on reported shares across multiple companies, which include ANTARES PHARMA, INC., and INKINE PHARMACEUTICAL CO INC.
SEC CIK
Robert F Apple's CIK is 0001054942
Past Insider Trading and Trends
2019 was Robert F Apple's most active year for acquiring shares with 9 total transactions. Robert F Apple's most active month to acquire stocks was the month of April. 2021 was Robert F Apple's most active year for disposing of shares, totalling 17 transactions. Robert F Apple's most active month to dispose stocks was the month of April. 2021 saw Robert F Apple paying a total of $1,570,210.98 for 1,489,639 shares, this is the most they've acquired in one year. In 2022 Robert F Apple cashed out on 7,210,810 shares for a total of $16,298,483.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANTARES PHARMA, INC. No price found
President and CEORobert F Apple used to own units in Common Stock but no longer holds any shares there. From 2006 to 2022 Robert F Apple acquired a total of 5,084,543 shares in ANTARES PHARMA, INC. at a cost of $6,990,868.45, Robert also disposed a total of 5,651,294 shares of ANTARES PHARMA, INC. equalling to $26,698,444.59.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.86M |
$5.60 | -$16,029,770.40 |
0
|
May 24
| |||
Form 4
| +2.01% | 49.12K |
$3.80 | -$143,241.00 | 2.49M |
Mar 3
| |||
Form 4
| +1.78% | 42.61K |
$3.66 | -$125,472.12 | 2.44M |
Feb 16
| |||
Form 4
| +6.66% | 149.66K |
$4.44 | $658,520.93 | 2.4M |
Jun 10 - Jun 13
| |||
Form 4
| -1.93% | -44.22K |
$4.39 | -$194,138.97 | 2.25M |
Jun 8
| |||
Form 4
| +3.92% | 86.43K |
$4.50 | -$298,485.00 | 2.29M |
Mar 1
| |||
Form 4
| -3.94% | -90.39K |
$2.94 | -$2,801,894.40 | 2.2M |
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4
|
—
|
0
|
$3.69 | -$191,659.53 | 2.3M |
Scheduled
|
Feb 8 - Feb 10
| ||
Form 4
| +18.73% | 362.04K |
$2.76 | $986,319.14 | 2.3M |
Jun 11 - Jun 13
| |||
Form 4
| -4.60% | -93.16K |
$3.12 | -$291,098.31 | 1.93M |
Jun 7 - Jun 8
| |||
Form 4
| +6.32% | 120.39K |
$3.53 | -$319,101.41 | 2.03M |
Feb 19
| |||
Form 4
|
—
|
0
|
$3.52 | -$830,640.26 | 1.91M |
Dec 9 - Dec 10
| |||
Form 4
| +3.06% | 56.55K |
$2.44 | -$53,787.65 | 1.91M |
Nov 11
| |||
Form 4
| +18.03% | 282.53K |
$2.92 | $824,999.28 | 1.85M |
Jun 13
| |||
Form 4
| -5.61% | -93.16K |
$2.81 | -$261,782.41 | 1.57M |
Jun 7 - Jun 8
| |||
Form 4
| -3.07% | -52.56K |
$2.79 | -$146,639.61 | 1.66M |
Jun 2
| |||
Form 4
| +11.89% | 181.96K |
$3.20 | -$231,184.00 | 1.71M |
Feb 20
| |||
Form 4
|
—
|
0
|
$2.11 | -$141,040.00 | 1.53M |
Scheduled
|
Aug 21
| ||
Form 4
| +21.76% | 273.52K |
$2.70 | $738,517.50 | 1.53M |
Jun 7 - Jun 8
| |||
Form 4
| -2.66% | -34.40K |
$2.69 | -$92,541.38 | 1.26M |
Jun 2
| |||
Form 4
| -1.03% | -13.48K |
$2.43 | -$32,756.40 | 1.29M |
May 28
| |||
Form 4
| +4.19% | 52.45K |
$1.69 | -$5,606.04 | 1.3M |
May 11
| |||
Form 4
| +6.54% | 76.83K |
$2.20 | -$81,402.20 | 1.25M |
Feb 22
| |||
Form 4/A
| +40.37% | 338.12K |
$2.66 | $899,385.90 | 1.18M |
Jun 7
| |||
Form 4
| -43.89% | -390.59K |
$2.64 | -$1,047,227.02 | 1.18M |
Feb 22 - Jun 7
| |||
Form 4
|
—
|
0
|
$2.33 | -$54,070.30 | 890K |
Scheduled
|
Apr 4 - Apr 5
| ||
Form 4
| +2.33% | 20.28K |
$1.79 | -$19,534.95 | 890K |
Dec 27 - Dec 27
| |||
Form 4
| +1.31% | 11.22K |
$1.05 | $11,784.15 | 869.72K |
Jun 30
| |||
Form 4
| +73.31% | 363.15K |
$1.12 | $406,728.00 | 858.5K |
Jun 2
| |||
Form 4
| -4.22% | -21.82K |
$0.91 | -$19,861.00 | 495.35K |
May 31
| |||
Form 4
| +13.12% | 60K |
$0.72 | $43,200.00 | 517.16K |
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +42.07% | 135.38K |
$2.14 | -$14,792.62 | 457.16K |
May 21 - May 28
| |||
Form 4/A
| +0.61% | 4.21K |
$2.67 | -$21,750.66 | 695.85K |
May 21 - Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +2.43% | 7.74K |
$2.36 | -$11,278.44 | 326.62K |
Feb 10
| |||
Form 4
| +28.23% | 97.09K |
—
|
—
| 441K |
May 29
| |||
Form 4
| -6.78% | -25.00K |
$4.45 | -$50,000.20 | 343.92K |
Feb 11
| |||
Form 4
|
—
|
0
|
$2.74 | -$45,300.00 | 368.92K |
Scheduled
|
Jan 10
| ||
Form 4
|
—
|
0
|
$2.76 | -$100,859.00 | 368.92K |
Scheduled
|
Oct 14
| ||
Form 4
|
—
|
0
|
$2.25 | -$407,868.76 | 368.92K |
Scheduled
|
Jun 3 - Jun 4
| ||
Form 4
| +22.33% | 67.34K |
—
|
—
| 368.92K |
May 22
| |||
Form 4
|
—
|
0
|
$2.25 | -$35,457.00 | 301.58K |
Scheduled
|
May 6
| ||
Form 4
|
—
|
0
|
$2.24 | -$88,540.00 | 310.27K |
Scheduled
|
Jan 8
| ||
Form 4
|
—
|
0
|
$2.24 | -$88,250.00 | 310.27K |
Scheduled
|
Dec 4
| ||
Form 4
| +8.78% | 25.04K |
—
|
—
| 310.27K |
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +16.36% | 40.11K |
—
|
—
| 285.23K |
Sep 9
| |||
Form 4
| +25.26% | 50K |
—
|
—
| 247.92K |
May 17
| |||
Form 4
| +20.77% | 34.04K |
—
|
—
| 197.92K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
| +6.67% | 10.42K |
—
|
—
| 166.68K |
Jul 21
| |||
Form 4
| +6.95% | 10.15K |
—
|
—
| 156.25K |
May 27
| |||
Form 4
| +65.18% | 50.42K |
—
|
—
| 127.77K |
Feb 22
| |||
Form 4
| +41.61% | 22.73K |
—
|
—
| 77.35K |
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
| +60.50% | 27.5K |
—
|
—
| 72.95K |
May 14
| |||
Form 4
| +100.00% | 22.73K |
—
|
—
| 45.45K |
Jan 10
| |||
Form 4
|
∞
| 22.73K |
—
|
—
| 22.73K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INKINE PHARMACEUTICAL CO INC No price found
COO & CFORobert F Apple used to own units in Common Stock but no longer holds any shares there.acquired a total of 255,080 shares in INKINE PHARMACEUTICAL CO INC at a cost of $248,039.00, Robert also disposed a total of 260,080 shares of INKINE PHARMACEUTICAL CO INC equalling to $1,041,417.04.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -45.08K |
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +801.60% | 40.08K |
—
|
—
| 45.08K |
Nov 18
| |||
Form 4
|
—
|
0
|
$3.26 | -$367,833.50 | 5K |
Nov 9
| |||
Form 4
|
—
|
0
|
$2.78 | -$425,544.54 | 60K |
Sep 22 - Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||